1/7
07:30 am
fgen
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
Medium
Report
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
12/15
07:05 am
fgen
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]
Low
Report
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]
12/15
07:00 am
fgen
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
Medium
Report
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration